Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | A302fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM A302fs results in a change in the amino acid sequence of the Atm protein beginning at aa 302 of 3056, likely resulting in premature truncation of the functional protein (UniProt.org). A302fs results in decreased protein expression and failure to induce expression of TP53 target genes upon DNA damage in patient-derived cells (PMID: 23585524), and therefore, is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM A302fs |
Transcript | NM_000051.4 |
gDNA | chr11:g.(108246965_108246966) |
cDNA | c.(904_903) |
Protein | p.A302fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005271562 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017792.2 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_017017792 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
XM_047426981.1 | chr11:g.(108246965_108246966) | c.(904_903) | p.A302fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|